Respiratory News and Research

RSS

Low-cost point of emission air purifiers can reduce airborne transmission of pathogens, says study

In a study conducted at the Monash University, Australia, scientists have examined the efficacy of portable air purifiers combined with a hood in reducing virus aerosol transmission and protecting healthcare workers from workplace contamination. The study is currently available on the medRxiv* preprint server.

20 Aug 2021

Researchers recommend urgent adaptation plans to mitigate heat-related deaths and illnesses

Extreme heat is an increasingly common occurrence worldwide, with heat-related deaths and illnesses also expected to rise.

20 Aug 2021

Millions of Africans are at risk of contracting COVID-19 due to lack of public health tools

Millions of people across the African continent are at risk of contracting COVID-19 because of a lack of the most basic public health tools to protect themselves - including the essentials of soap and water.

20 Aug 2021

Research finds potential overuse of antibiotics in patients with severe SARS-CoV-2 pneumonia

Only 21 percent of patients with severe pneumonia caused by SARS-CoV-2 (the virus that causes COVID-19) have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

20 Aug 2021

Chemical Insights, Underwriters Laboratories and GSU launch research initiative on vaping and e-cigarettes

Chemical Insights Research Institute, Underwriters Laboratories Inc., and Georgia State University's School of Public Health announced the launch of a research initiative on understanding human exposure and the potential health effects of vaping and e-cigarettes.

20 Aug 2021

Researchers discover glycan 'gates' that open to allow SARS-CoV-2 entry

Since the early days of the COVID pandemic, scientists have aggressively pursued the secrets of the mechanisms that allow severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter and infect healthy human cells.

19 Aug 2021

Existing drugs block or reduce SARS-CoV2 infection in cells

Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat COVID-19. And while the COVID-19 vaccines represent the best measure to prevent the disease, therapies for those who do get infected remain in short supply.

19 Aug 2021

Vaccine quickly reduced COVID-19 infections among health care workers

A UC Davis Health retrospective study published recently in Infection Control and Hospital Epidemiology shows how quickly COVID-19 infections were reduced among health care workers when vaccines were first distributed late last year.

19 Aug 2021

Study highlights the importance of better face masks and good ventilation to mitigate COVID-19 indoors

A new study is highlighting a need for widespread use of better face masks and the importance of good ventilation to mitigate the spread of COVID-19 indoors.

19 Aug 2021

Experts recommend key steps to make re-opening of universities safer in autumn

Offering covid-19 vaccinations on campus, delayed or phased autumn re-openings, and mandatory face mask wearing are among the steps universities and colleges could take to make them safer places for students returning to, or starting, their studies this autumn, say public health experts in an opinion piece in The BMJ.

19 Aug 2021

Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels

In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.

19 Aug 2021

SARS-CoV-2 antibodies found to neutralize bat coronavirus (RaTG13) in new study

A striking new study examines how far antibodies elicited by vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or by natural infection, can neutralize the closely related bat coronavirus (CoV) RaTG13.

19 Aug 2021

How does the SARS-CoV-2 Delta variant’s spike drive membrane fusion and immunity evasion?

A fascinating and timely new study shows how the Delta variant of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) achieved higher transmissibility and resistance to neutralization.

19 Aug 2021

Durable highly protective T cell response to AAV-spike vaccine against COVID-19 pneumonia in mice

New research, available as a preprint on the bioRxiv* server, has focused on the role played by T cell immunity, particularly CD8+ cytotoxic T cells, on preventing lethal infection with SARS-CoV-2 in mice infused with peptide-loaded antigen-presenting dendritic cells (DCs).

19 Aug 2021

Did particulate matter from wildfires cause excess COVID-19 deaths in the US?

New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.

19 Aug 2021

Early clinical trial data in for whole virus COVID-19 vaccine candidate

In a study uploaded to the preprint server medRxiv*, the efficacy of a whole virion Coronavirus vaccine was determined by giving the vaccine to healthy adult volunteers, which generated a robust immune response with evidence of T-cell activation.

19 Aug 2021

To stoke rural vaccination rates, trusted farmers are asked to spread word

When he became eligible for the coronavirus vaccine in Illinois, Tom Arnold, 68, said he didn’t need any convincing. He raises cattle, hogs and chickens in Elizabeth, a small town in the state's northwestern corner.

19 Aug 2021

Scientists identify a potent neutralizing nanobody against SARS-CoV-1

In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.

19 Aug 2021

White-tailed deer are highly susceptible to SARS-CoV-2 infection

The SARS-CoV-2 virus has been shown to infect a wide range of animals naturally and experimentally, and prior studies indicate deer are susceptible to infection. White-tailed deer (Odocoileus virginianus) fawns have been found to be susceptible to SARS-CoV-2.

19 Aug 2021

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However, the researchers suggest that booster shots may help improve immunity and protect against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

18 Aug 2021

Respiratory News and Research

Low-cost point of emission air purifiers can reduce airborne transmission of pathogens, says study

Researchers recommend urgent adaptation plans to mitigate heat-related deaths and illnesses

Millions of Africans are at risk of contracting COVID-19 due to lack of public health tools

Research finds potential overuse of antibiotics in patients with severe SARS-CoV-2 pneumonia

Chemical Insights, Underwriters Laboratories and GSU launch research initiative on vaping and e-cigarettes

Researchers discover glycan 'gates' that open to allow SARS-CoV-2 entry

Existing drugs block or reduce SARS-CoV2 infection in cells

Vaccine quickly reduced COVID-19 infections among health care workers

Study highlights the importance of better face masks and good ventilation to mitigate COVID-19 indoors

Experts recommend key steps to make re-opening of universities safer in autumn

Small study suggests a mix-and-match COVID-19 booster produces robust antibody levels

SARS-CoV-2 antibodies found to neutralize bat coronavirus (RaTG13) in new study

How does the SARS-CoV-2 Delta variant’s spike drive membrane fusion and immunity evasion?

Durable highly protective T cell response to AAV-spike vaccine against COVID-19 pneumonia in mice

Did particulate matter from wildfires cause excess COVID-19 deaths in the US?

Early clinical trial data in for whole virus COVID-19 vaccine candidate

To stoke rural vaccination rates, trusted farmers are asked to spread word

Scientists identify a potent neutralizing nanobody against SARS-CoV-1

White-tailed deer are highly susceptible to SARS-CoV-2 infection

SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News